Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
In a 12-week phase 2a study, individuals with obesity were treated with weekly doses of 4 mg, 6 mg, or placebo
What the research shows Backed by published science
Semaglutide 2.4 mg (Wegovy) has shown robust weight loss in primary obesity trials, with mean weight reductions of 14.9% in the STEP 1 trial published in the New England Journal of Medicine (2021)
TB-500 is studied in the context of actin dynamics, cell motility, and ECM remodeling
Glutathione injections brighten skin internally by inhibiting the tyrosinase enzyme, which plays a key role in melanin production
US$ 26.60
US$ 25.27
US$ 29.23
US$ 21.78
